Introduction: Beyond the Chatbot When you ask ChatGPT a question, it answers. When you ask an agentic AI system a question, it acts. This distinction — between passive assistance and autonomous execution — marks one of the most significant shifts in artificial intelligence since the transformer architecture itself. Agentic AI systems are not merely more sophisticated chatbots. They are autonomous entities capable of perception, reasoning, planning, tool use, action, and memory. They can independently execute multi-step workflows, make decisions when faced with uncertainty, and adapt their approach based on feedback from the environment. In scientific contexts, this means agents that can read literature, formulate hypotheses, design experiments, execute computational analyses, interpret results, and iterate — all with varying degrees of human oversight. ...

Introduction: The Cellular Resolution Frontier Biology has always been a story of scale. For decades, we studied organisms, then tissues, then cell populations — averaging signals across thousands or millions of cells. But tissues are not homogeneous. A tumor contains cancer cells, immune cells, fibroblasts, and endothelial cells, each with distinct molecular profiles. The brain contains hundreds of neuronal subtypes, each with unique functions. Even “identical” cells in culture exhibit stochastic variation in gene expression that can determine cell fate. ...

Imagine two friends. One is a computational biologist, spending their days deciphering the human genome, designing complex experiments, and navigating the physical limitations of the natural world to find a cure for a rare disease. The other is a tech lead at a major software company, designing the architecture for a new feature on a widely used app. The biologist works longer hours, required a decade of post-graduate education to get their job, and arguably contributes more to the long-term survival of humanity. Yet, the software engineer earns three times their salary. Why? ...

The Visible Layer of Biology While genomics reads the book of life and proteomics predicts the machinery that executes it, phenomics observes the actual outcome—the visible traits, cellular morphologies, and clinical presentations that emerge from the interplay of genes, environment, and chance. It is the layer we can see, measure, and often directly connect to disease. Yet phenomics has historically been the poor cousin of molecular omics. High-throughput sequencing transformed genomics and transcriptomics into data-rich disciplines, while phenotyping remained labor-intensive, subjective, and low-throughput. A pathologist examining tissue slides. A physician recording clinical observations. A biologist peering through a microscope. ...

AI for Metagenomics: Decoding the Microbiome The human microbiome is often referred to as our “second genome.” Comprising trillions of microorganisms—bacteria, archaea, fungi, and viruses—these hidden ecosystems outnumber human cells and contain vastly more genetic diversity than our own DNA. But where human genomics deals with a single species and a relatively static genome, metagenomics is the study of a dynamic, highly complex, and constantly shifting multi-species community. Decoding the microbiome is arguably one of the most data-rich and complex challenges in modern biology. Traditional bioinformatics tools, while foundational, have struggled with the compositionality, sparsity, and high dimensionality of metagenomic data. ...

Welcome back to Agentic Omics: When AI Reads the Book of Life. In our previous installments, we explored how foundation models and artificial intelligence are revolutionizing genomics, transcriptomics, and proteomics. We’ve seen how DNA, RNA, and proteins can be treated as languages, allowing transformer architectures to parse their meaning with unprecedented accuracy. Today, we turn to a different beast: Metabolomics. Metabolomics—the large-scale study of small molecules, or metabolites, within cells, biofluids, tissues, or organisms—represents the chemical phenotype of biological systems. Unlike DNA or proteins, which are linear polymers built from defined alphabets (4 nucleotides, 20 amino acids), metabolites are incredibly diverse structural entities. They do not form a neat sequence. They are the downstream products of gene expression and protein activity, intimately influenced by diet, environment, and microbiome. They are the chemical fingerprint of life at a given moment. ...

Protein artificial intelligence is, without question, the most mature and publicly celebrated discipline within the “omics” family. When we discuss AI in biology, the conversation inevitably drifts toward the 2024 Nobel Prize in Chemistry—awarded jointly to David Baker for computational protein design, and to Demis Hassabis and John Jumper for protein structure prediction via AlphaFold. However, structure prediction was merely the opening act. Today, the frontier has rapidly shifted from static structure prediction to protein design (creating entirely new proteins), function prediction, and complex interaction modeling. In this seventh installment of the Agentic Omics series, we will dissect the current state of AI in proteomics, evaluate the monumental shifts from AlphaFold 2 to AlphaFold 3 and ESM-3, explore generative models like ProGen and RFdiffusion, and critically assess their real-world clinical impact in drug discovery. ...

Introduction: The Language of the Cell While genomics maps the static blueprint of life, transcriptomics captures its dynamic execution. If the genome is the dictionary, the transcriptome is the conversation—the precise subset of genes being expressed by a specific cell, at a specific moment, under specific conditions. For decades, bulk RNA sequencing averaged these conversations across millions of cells, giving us a cacophonous blend that masked individual cellular identities. The advent of single-cell RNA sequencing (scRNA-seq) changed everything, allowing us to listen to individual cellular voices. ...

The genome is the ultimate source code. For decades, computational biologists have relied on alignment algorithms, hidden Markov models, and specialized machine learning to decode it. Today, a new paradigm is taking hold: DNA foundation models. By treating the genome as a vast, continuous text and training large language models (LLMs) on billions of nucleotides, researchers are teaching AI to “read” the book of life in its native language. In this fifth installment of our Agentic Omics series, we examine the state of the art in genomic AI. We explore how models like DNABERT-2, Nucleotide Transformer, Evo, and HyenaDNA are moving beyond sequence classification to predict gene expression, identify regulatory elements, and quantify variant effects. Crucially, we will dissect the architectural innovations that make this possible—and the biological complexities that still confound these models. ...

When a new foundation model in computational biology is released, the accompanying paper inevitably features tables of bolded numbers demonstrating state-of-the-art performance. Whether it is predicting protein structures or annotating single-cell data, the claims are often spectacular. But how do we truly know if these AI systems work in ways that matter to biology, rather than just optimizing arbitrary computational metrics? For the vision of Agentic Omics to become reality—where autonomous agents orchestrate models like AlphaFold and DNABERT-2 to drive drug discovery—we need a rigorous understanding of when these models succeed, when they hallucinate, and when their benchmarks deceive us. Claims of AI breakthroughs are only as strong as their evaluation methodologies. ...